Total Payments
$12,450
2024 Payments
$4,056
Companies
24
Transactions
104
Medicare Patients
8,322
Medicare Billing
$685,658
Payment Breakdown by Category
Consulting$7,270 (58.4%)
Food & Beverage$2,862 (23.0%)
Travel$2,217 (17.8%)
Education$100.89 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,270 | 2 | 58.4% |
| Food and Beverage | $2,862 | 91 | 23.0% |
| Travel and Lodging | $2,217 | 9 | 17.8% |
| Education | $100.89 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $5,474 | 16 | $0 (2019) |
| Janssen Biotech, Inc. | $4,345 | 16 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $1,090 | 11 | $0 (2017) |
| Astellas Pharma US Inc | $356.51 | 10 | $0 (2024) |
| AbbVie, Inc. | $247.87 | 14 | $0 (2018) |
| Dendreon Pharmaceuticals LLC | $197.35 | 2 | $0 (2023) |
| Endo Pharmaceuticals Inc. | $162.67 | 5 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $118.85 | 7 | $0 (2019) |
| Amgen Inc. | $50.67 | 3 | $0 (2019) |
| Merck Sharp & Dohme LLC | $48.16 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,056 | 8 | Janssen Biotech, Inc. ($3,916) |
| 2023 | $495.51 | 6 | Janssen Biotech, Inc. ($250.00) |
| 2022 | $15.88 | 1 | Celgene Corporation ($15.88) |
| 2019 | $247.15 | 13 | Janssen Biotech, Inc. ($69.03) |
| 2018 | $5,883 | 35 | Bayer HealthCare Pharmaceuticals Inc. ($5,342) |
| 2017 | $1,752 | 41 | Valeant Pharmaceuticals North America LLC ($1,090) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $121.85 | General |
| Category: Oncology | ||||||
| 04/29/2024 | CIVCO Medical Instruments | — | Food and Beverage | Cash or cash equivalent | $18.32 | General |
| 03/14/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $142.64 | General |
| Category: Oncology | ||||||
| 02/02/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Consulting Fee | Cash or cash equivalent | $3,270.00 | General |
| Category: Oncology | ||||||
| 01/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Travel and Lodging | In-kind items and services | $405.67 | General |
| Category: Oncology | ||||||
| 01/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $43.05 | General |
| Category: Oncology | ||||||
| 01/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: Oncology | ||||||
| 01/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Oncology | ||||||
| 10/23/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $24.08 | General |
| 10/23/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $24.08 | General |
| 09/27/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $138.02 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/27/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $59.33 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 03/16/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 03/16/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 11/15/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.88 | General |
| Category: Neuroscience | ||||||
| 07/08/2019 | Amgen Inc. | Prolia (Biological), XGEVA | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Bone Health | ||||||
| 07/01/2019 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| 06/04/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: Oncology | ||||||
| 05/14/2019 | Ferring Pharmaceuticals Inc. | NOCDURNA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: UROLOGY | ||||||
| 04/30/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: ONCOLOGY | ||||||
| 03/25/2019 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Oncology | ||||||
| 03/12/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Oncology | ||||||
| 03/05/2019 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: UROLOGY | ||||||
| 02/26/2019 | Janssen Scientific Affairs, LLC | Erleada (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Oncology | ||||||
| 02/18/2019 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,067 | 3,516 | $669,399 | $167,649 |
| 2022 | 27 | 2,082 | 3,487 | $702,300 | $167,930 |
| 2021 | 29 | 1,975 | 3,373 | $715,802 | $166,292 |
| 2020 | 39 | 2,198 | 4,213 | $754,518 | $183,786 |
Total Patients
8,322
Total Services
14,589
Medicare Billing
$685,658
Procedure Codes
121
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 55700 | Biopsy of prostate gland | Office | 2023 | 206 | 206 | $204,008 | $47,774 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 313 | $138,088 | $35,497 | 25.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 209 | 209 | $102,753 | $26,788 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 199 | $62,267 | $15,486 | 24.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 206 | 206 | $47,524 | $12,353 | 26.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 27 | 30 | $28,805 | $6,866 | 23.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 39 | 75 | $12,906 | $3,539 | 27.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 28 | $12,501 | $3,427 | 27.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 138 | 240 | $11,430 | $2,483 | 21.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 140 | 234 | $2,106 | $1,949 | 92.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 34 | $6,720 | $1,788 | 26.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 212 | 455 | $4,750 | $1,545 | 32.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 18 | $4,855 | $1,331 | 27.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 55 | 64 | $3,531 | $1,153 | 32.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 50 | 79 | $12,147 | $994.66 | 8.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 28 | 28 | $2,520 | $969.36 | 38.5% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 46 | 73 | $1,767 | $577.43 | 32.7% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 26 | 66 | $1,713 | $559.40 | 32.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 35 | $1,713 | $469.70 | 27.4% |
| J0690 | Injection, cefazolin sodium, 500 mg | Office | 2023 | 191 | 764 | $1,879 | $442.47 | 23.5% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 20 | 20 | $1,514 | $378.40 | 25.0% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 16 | 19 | $1,048 | $342.38 | 32.7% |
| 87088 | Bacterial urine culture | Office | 2023 | 27 | 39 | $946.53 | $309.27 | 32.7% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 27 | 39 | $945.36 | $308.88 | 32.7% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 11 | 11 | $851.73 | $278.19 | 32.7% |
About Dr. Theodore Felderman, MD
Dr. Theodore Felderman, MD is a Urology healthcare provider based in Plainview, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710940622.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Theodore Felderman, MD has received a total of $12,450 in payments from pharmaceutical and medical device companies, with $4,056 received in 2024. These payments were reported across 104 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($7,270).
As a Medicare-enrolled provider, Felderman has provided services to 8,322 Medicare beneficiaries, totaling 14,589 services with total Medicare billing of $685,658. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Plainview, NY
- Active Since 04/11/2006
- Last Updated 04/02/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1710940622
Products in Payments
- Xofigo (Drug) $5,474
- ERLEADA (Drug) $4,166
- PROVENGE (Drug) $1,288
- Xtandi (Drug) $248.37
- Androgel (Drug) $229.06
- XIAFLEX (Biological) $162.67
- XTANDI (Drug) $159.74
- Erleada (Drug) $152.23
- FIRMAGON (Drug) $83.93
- ZYTIGA (Drug) $46.90
- MAGIC3 (Device) $45.13
- UroLift (Device) $36.79
- NOCDURNA (Drug) $34.92
- XGEVA (Biological) $30.74
- VIAGRA (Drug) $25.50
- NICORE (Device) $25.36
- ELIGARD (Drug) $23.35
- Myrbetriq (Drug) $23.31
- Glydo (Drug) $22.67
- Prolia (Biological) $19.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Plainview
Alfred Kohan, Md, MD
Urology — Payments: $69,017
Urology $69,017
Jeffrey Layne, Md, MD
Urology — Payments: $4,391
Urology $4,391
Dr. Jeffrey Haberman, Md, MD
Urology — Payments: $3,717
Urology $3,717
Robert Luntz, Md, MD
Urology — Payments: $3,257
Urology $3,257
Dr. Tso-Jen Hsiao, M.d, M.D
Urology — Payments: $352.10
Urology $352.10
Dr. Elliott Lieberman, M.d, M.D
Urology — Payments: $349.79
Urology $349.79